title: Reply.
authors.affiliation: Hospital Vall d'Hebrón Network Center for Biomedical Research in Hepatic and Digestive Disease, Barcelona, Spain.
authors.forename: Itxarone
authors.initials: I
authors.lastname: Bilbao
authors.affiliation: Novartis Farmacéutica, Barcelona, Spain.
authors.forename: Magda
authors.initials: M
authors.lastname: Guilera
mesh_terms: D057915:Drug Substitution; D000068338:Everolimus / Q000008:administration & dosage*; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007668:Kidney / Q000187:drug effects*; D016031:Liver Transplantation; D008297:Male
chemical_list: D007166:Immunosuppressive Agents; D000068338:Everolimus